• 제목/요약/키워드: T1/2 gastric cancer

검색결과 198건 처리시간 0.024초

Long-term Efficacy of S-1 Monotherapy or Capecitabine Plus Oxaliplatin as Adjuvant Chemotherapy for Patients with Stage II or III Gastric Cancer after Curative Gastrectomy: a Propensity Score-Matched Multicenter Cohort Study

  • Lee, Chang Min;Yoo, Moon-Won;Son, Young-Gil;Oh, Sung Jin;Kim, Jong-Han;Kim, Hyoung-Il;Park, Joong-Min;Hur, Hoon;Jee, Ye Seob;Hwang, Sun-Hwi;Jin, Sung-Ho;Lee, Sang Eok;Park, Ji-Ho;Seo, Kyung Won;Park, Sungsoo;Kim, Chang Hyun;Jeong, In Ho;Lee, Han Hong;Choi, Sung Il;Lee, Sang-Il;Kim, Chan Young;Kim, In-Hwan;Son, Myoung-Won;Pak, Kyung Ho;Kim, Sungsoo;Lee, Moon-Soo;Min, Jae-Seok
    • Journal of Gastric Cancer
    • /
    • 제20권2호
    • /
    • pp.152-164
    • /
    • 2020
  • Purpose: To compare long-term disease-free survival (DFS) between patients receiving tegafur/gimeracil/oteracil (S-1) or capecitabine plus oxaliplatin (CAPOX) adjuvant chemotherapy (AC) for gastric cancer (GC). Materials and Methods: This retrospective multicenter observational study enrolled 983 patients who underwent curative gastrectomy with consecutive AC with S-1 or CAPOX for stage II or III GC at 27 hospitals in Korea between February 2012 and December 2013. We conducted propensity score matching to reduce selection bias. Long-term oncologic outcomes, including DFS rate over 5 years (over-5yr DFS), were analyzed postoperatively. Results: The median and longest follow-up period were 59.0 and 87.6 months, respectively. DFS rate did not differ between patients who received S-1 and CAPOX for pathologic stage II (P=0.677) and stage III (P=0.899) GC. Moreover, hazard ratio (HR) for recurrence did not differ significantly between S-1 and CAPOX (reference) in stage II (HR, 1.846; 95% confidence interval [CI], 0.693-4.919; P=0.220) and stage III (HR, 0.942; 95% CI, 0.664-1.337; P=0.738) GC. After adjustment for significance in multivariate analysis, pT (4 vs. 1) (HR, 11.667; 95% CI, 1.595-85.351; P=0.016), pN stage (0 vs. 3) (HR, 2.788; 95% CI, 1.502-5.174; P=0.001), and completion of planned chemotherapy (HR, 2.213; 95% CI, 1.618-3.028; P<0.001) were determined as independent prognostic factors for DFS. Conclusions: S-1 and CAPOX AC regimens did not show significant difference in over-5yr DFS after curative gastrectomy in patients with stage II or III GC. The pT, pN stage, and completion of planned chemotherapy were prognostic factors for GC recurrence.

Preemptive pyloroplasty for iatrogenic vagus nerve injury in intrahepatic cholangiocarcinoma patients undergoing extensive left-sided lymph node dissection: a retrospective observational study

  • Hwang, Shin;Jung, Dong-Hwan;Jwa, Eun-Kyoung;Kim, Yumi
    • Journal of Yeungnam Medical Science
    • /
    • 제39권3호
    • /
    • pp.235-243
    • /
    • 2022
  • Background: Intrahepatic cholangiocarcinoma (ICC) of the left liver often shows left-sided lymph node (LN) metastasis. If gastric lesser curvature is extensively dissected, it can induce an iatrogenic injury to the extragastric vagus nerve branches that control motility of the pyloric sphincter and lead to gastric stasis. To cope with such LN dissection-associated gastric stasis, we performed pyloroplasty preemptively. The objective of this study was to analyze our 20-year experience of preemptive pyloroplasty performed in 10 patients. Methods: We investigated clinical sequences of 10 patients with ICC who underwent preemptive pyloroplasty following left hepatectomy and extended left-sided LN dissection. Incidence of gastric stasis and oncological survival outcomes were analyzed. Results: All 10 patients were classified as stage IIIB due to T1-3N1M0 stage according to the 8th edition of American Joint Committee on Cancer staging system. The overall patient survival rate was 51.9% at 1 year, 25.9% at 2 years, and 0% at 3 years. Seven patients showed uneventful postoperative recovery after surgery. Two patients suffered from gastric stasis, which was successfully managed with supportive care. One patient suffered from overt gastric paresis, which was successfully managed with azithromycin administration for 1 month. Conclusion: We believe that preemptive pyloroplasty is an effective surgical option to prevent gastric stasis in patients undergoing extensive left-sided LN dissection. Azithromycin appears to be a potent prokinetic agent in gastroparesis.

Proteomics Analysis of Gastric Epithelial AGS Cells Infected with Epstein-Barr Virus

  • Ding, Yong;Li, Xiao-Rong;Yang, Kai-Yan;Huang, Li-Hua;Hu, Gui;Gao, Kai
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권1호
    • /
    • pp.367-372
    • /
    • 2013
  • Effects of the Epstein-Barr virus (EBV) on cellular protein expression are essential for viral pathogenesis. To characterize the cellular response to EBV infection, differential proteomes of gastric epithelial AGS cells were analyzed with two-dimensional gel electrophoresis (2-DE) followed by matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) and liquid chromatography electrospray/ionization ion trap (LC-ESI-IT) mass spectrometry identification. Mass spectrometry identified 9 altered cellular proteins, including 5 up-regulated and 4 down-regulated proteins after EBV infection. Notably 2-DE analysis revealed that EBV infection induced increased expression of heat shock cognate 71 kDa protein, actin cytoplasmic 1, pyridoxine-5'-phosphate oxidase, caspase 9, and t-complex protein 1 subunit alpha. In addition, EBV infection considerably suppressed those cellular proteins of zinc finger protein 2, cyclin-dependent kinase 2, macrophage-capping protein, and growth/differentiation factor 11. Furthermore, the differential expressional levels of partial proteins (cyclin-dependent kinase 2 and caspase 9) were confirmed by Western blot analysis.Thus, this work effectively provided useful protein-related information to facilitate further investigation of the mechanisms underlying EBV infection and pathogenesis.

스트레스 반응으로 나타나는 활력증상 변화에 대한 실증적연구 (A Study of the Difference of Vital Sign by Stress Reaction)

  • 김희승;한윤복;김명자;노유자
    • 대한간호학회지
    • /
    • 제17권2호
    • /
    • pp.137-144
    • /
    • 1987
  • The main purpose of this study was to examine the validity of the vital sign as an instrument of stress reaction measurement. From July to August 1986, stress reaction was evaluated by the difference of endoscopic vital sign on 93 G-I troubled out-patients who underwent endoscopy for the first time and did not have any evidence of cardiovascular disease. The data were analysed by x$^2$-test, Paired . t-test, ANCOVA and Multiple Comparison Test. The result of study were as follows: 1. The frequency of gastric disease was differed by the family type, and the mobility of gastritis and gastric cancer were more increased in nuclear family than in large family (p=0.019). 2. In a comparison of before with after 5 minutes endoscopic vital sign, and a Pulse rate (P=0.0001), respiration rate (p=0.0001), systolic blood pressure (p=0.0002) and diastolic blood Pressure (P=0.006) were significantly increased after 5minutes by endoscopy in contrast with before 5minutes. 3. The control of before 5 minutes of endoscopic vital sign, after 5 minutes of endoscopic systolic (p=0.024) and diastolic blood pressure (p=0.0146) were more elevated in biopsyed group than in non-biopsyed, group. And after 5minutes of endoscopic respiration rate was more increased in gastric cancer than in gastritis (p=0.0406) or gastric ulcer (p=0.0073). And after 5 minutes of endoscopic systolic blood pressure was elevated over 50years old men (P=0.0238). In short, the increase of a pulse rate af ter 5 minutes of endoscopy was not influenced by general characteristics of samples in this experiment. And systolic blood pressure over 50years old men must be considered of physiological hypertension.

  • PDF

Endoscopic ultrasound-guided gastrojejunostomy with a direct technique without previous intestinal filling using a tubular fully covered self-expandable metallic stent

  • Hakan Senturk;Ibrahim Hakki Koker;Koray Kochan;Sercan Kiremitci;Gulseren Seven;Ali Tuzun Ince
    • Clinical Endoscopy
    • /
    • 제57권2호
    • /
    • pp.209-216
    • /
    • 2024
  • Background/Aims: Endoscopic ultrasonography-guided gastrojejunostomy is a minimally invasive method for the management of gastric outlet obstruction. Conventionally, a lumen-apposing metal stent (LAMS) is used to create an anastomosis. However, LAMS is expensive and not widely available. In this report, we described a tubular fully covered self-expandable metallic stent (T-FCSEMS) for this purpose. Methods: Twenty-one patients (15 men [71.4%]; median age, 66 years; range, 40-87 years) were included in this study. A total of 19 malignant (12 pancreatic, 6 gastric, and 1 metastatic rectal cancer) and 2 benign cases were observed. The proximal jejunum was punctured with a 19 G needle. The stomach and jejunum walls were dilated with a 6 F cystotome, and a 20×80 mm polytetrafluoroethylene T-FCSEMS (Hilzo) was deployed. Oral feeding was initiated after 12 to 18 hours and solid foods after 48 hours. Results: The median procedure time was 33 minutes (range, 23-55 minutes). After two weeks, 19 patients tolerated oral feeding. In patients with malignancy, the median survival time was 118 days (range, 41-194 days). No serious complications or deaths occurred. All patients with malignancy tolerated oral food intake until they expired. Conclusions: T-FCSEMS is safe and effective. This stent should be considered as an alternative to LAMS for gastric outlet obstruction.

감잎의 물 및 에탄올 추출물이 한국인 위암 세포주에 미치는 항암효과 (Anticancer Effect of Persimmon Leaf Extracts on Korean Gastric Cancer Cell)

  • 김호정;김미경
    • Journal of Nutrition and Health
    • /
    • 제36권2호
    • /
    • pp.133-146
    • /
    • 2003
  • This study was performed to investigate the in vitro and in vivo anticancer effects of persimmon leaf extracts on human gastric cancer cells. In vitro anticancer effects of persimmon leaf extracts (water extract at 8$0^{\circ}C$ for 3 hours, water extract at room temperature for 48 hours, 50% ethanol extract at 8$0^{\circ}C$ for 3 hours, 50% ethanol extract at room temperature for 48 hours, 75% ethanol extract at 8$0^{\circ}C$ for 3 hours and 75% ethanol extract at room temperature for 48 hours) on SNU16 (Korean gastric cancer cell) were investigated by MTT assay. Persimmon leaf extracts exhibited strong in vitro anticancer effects. We found that the higher the ethanol content of the solvent, the stronger the in vitro anticancer effects. Extraction yields, contents of flavonoids, vitamin A, vitamin C and vitamin E were measured. We found that the higher the ethanol content of the solvent, the higher the extraction yields and the contents of flavonoids, vitamin A and vitamin E. Among persimmon leaf extracts, 75% ethanol 8$0^{\circ}C$ extract showed the highest extraction yield, the highest contents of flavonoids, vitamin A and vitamin E and exhibitied the strongest in vitro anticancer effect on SNU16. Therefore, 75% ethanol 8$0^{\circ}C$ extract was chosen as the material to investigate in vivo anticancer effects. In vivo anticancer effect of persimmon leaf 75% ethanol 8$0^{\circ}C$ extract was investigated in SNU16 transplanted nude mice. Twenty five female nude mice (BALB/c) were blocked into five groups according to body weight and raised for 4 weeks with diets containing 4% (w/w), 8% (w/w) persimmon leaf 75% ethanol 8$0^{\circ}C$ extract, with IT (intratumoral) injection treatment with 1.65 mg/100 $\mu$1, 3.3 mg/100 $\mu$1 concentration every other day 3 weeks after SNU16 was transplanted. Persimmon 75% ethanol 8$0^{\circ}C$ extract significantly lowered tumor weight and tumor volume in SNU16 transplanted nude mice. Tumor weight and tumor volume in all experimental groups were significantly lower than those in the control group. Helper T cell (CD4) levels of mice injected with 3.3 mg/100 $\mu$1 extract significantly increased. Cytotoxic T cell (CD8) levels in all experimental groups significantly increased and helper/cytotoxic T cell ratios in all experimental groups significantly decreased. Natural killer cell and MHC class II molecule in all experimental groups significantly increased. In conclusion, persimmon leaf 75% ethanol 8$0^{\circ}C$ extract exhibited strong in vitro and in vivo anticancer effects against SNU16 cells and it increased cytotoxic T cell, natural killer cell and MHC classII molecule in experimental groups in SNU16 transplanted nude mice.

A Nomogram for Predicting Extraperigastric Lymph Node Metastasis in Patients With Early Gastric Cancer

  • Hyun Joo Yoo;Hayemin Lee;Han Hong Lee;Jun Hyun Lee;Kyong-Hwa Jun;Jin-jo Kim;Kyo-young Song;Dong Jin Kim
    • Journal of Gastric Cancer
    • /
    • 제23권2호
    • /
    • pp.355-364
    • /
    • 2023
  • Background: There are no clear guidelines to determine whether to perform D1 or D1+ lymph node dissection in early gastric cancer (EGC). This study aimed to develop a nomogram for estimating the risk of extraperigastric lymph node metastasis (LNM). Materials and Methods: Between 2009 and 2019, a total of 4,482 patients with pathologically confirmed T1 disease at 6 affiliated hospitals were included in this study. The basic clinicopathological characteristics of the positive and negative extraperigastric LNM groups were compared. The possible risk factors were evaluated using univariate and multivariate analyses. Based on these results, a risk prediction model was developed. A nomogram predicting extraperigastric LNM was used for internal validation. Results: Multivariate analyses showed that tumor size (cut-off value 3.0 cm, odds ratio [OR]=1.886, P=0.030), tumor depth (OR=1.853 for tumors with sm2 and sm3 invasion, P=0.010), cross-sectional location (OR=0.490 for tumors located on the greater curvature, P=0.0303), differentiation (OR=0.584 for differentiated tumors, P=0.0070), and lymphovascular invasion (OR=11.125, P<0.001) are possible risk factors for extraperigastric LNM. An equation for estimating the risk of extraperigastric LNM was derived from these risk factors. The equation was internally validated by comparing the actual metastatic rate with the predicted rate, which showed good agreement. Conclusions: A nomogram for estimating the risk of extraperigastric LNM in EGC was successfully developed. Although there are some limitations to applying this model because it was developed based on pathological data, it can be optimally adapted for patients who require curative gastrectomy after endoscopic submucosal dissection.

위암조직에서 p53 유전자의 돌연변이 (p53 Gene Mutation in Gastric Cancer Tissue)

  • 구기범;박성훈;정호영;이명훈;유완식
    • Journal of Gastric Cancer
    • /
    • 제6권4호
    • /
    • pp.214-220
    • /
    • 2006
  • 목적: 종양 억제, 세포 주기 조절 및 세포 고사의 기능과 연관 있는 유전자인 p53은 인간 종양에서 가장 흔히 발견되는 돌연변이 유전자로 알려져 있다. 위암에 있어서 p53의 돌연변이 정도와 생존율 등을 비교하여 각각의 상관관계와 예후 인자로써의 유용성에 대해 알아보고자 하였다. 방법: 1999년 3월부터 2001년 4월까지 경북대학교병원에서 위암으로 수술한 331명 환자의 조직을 이용하여, polymerase chain reaction single-strand conformation polymorphism 방법으로 p53 돌연변이를 확인하고, 환자의 임상 병리학적 인자와의 관계를 비교하였고, 환자의 생존율을 비교하였다. 결과: 전체 331명의 환자들의 조직 중 66예(19.9%)의 조직에서 p53 돌연변이가 관찰되었다. 이들 66예 중에서 exon 5에서 23예, exon 6에서 8예, exon 7에서 21예, exon 8에서 17예의 돌연변이를 보였는데, 이중 3예에서 2개의 exon에 돌연변이(exon 5와 exon 6, exon 6과 exon 7, exon 6과 exon 8)를 보였다 p53 돌연변이는 나이와 성별, 육안형, 병리학적 병기, 조직학적 분류, 종양의 위치에 따라서 차이는 없었으나, 장형 156예 중 36예(23.1%), 미만형 145예 중 19예(13.1%)로 유의한 차이가 있었고(P=0.007), p53 돌연변이에 따른 생존기간은 유의한 차이가 없었다(P=0.632). Exon 5는 장형(9.7%)에서 미만형(2.8%))보다 p53 돌연변이 빈도가 높았고(P=0.024), 림프절 전이가 있는 군에서 림프절 전이가 없는 군보다 p53 돌연변이의 빈도가 유의하게 높았다(25.0% vs 15.6%, P=0.034). 나머지 항목에서는 통계학적으로 유의한 차이가 없었다. 근치적 절제술을 시행한 예에서의 p53 돌연변이에 따른 생존율은 유의한 차이를 보이지 않았다(P=0.704). 결론: p53 돌연변이는 위암 환자의 예후인자로써 가치가 충분하지 않다.

  • PDF

위부분절제술 후 방사선치료에서 음식물 배출지연에 따른 영향 (Influence of Delayed Gastric Emptying in Radiotherapy after a Subtotal Gastrectomy)

  • 김동현;김원택;이미란;기용간;남지호;박달;전호상;전계록;김동원
    • Radiation Oncology Journal
    • /
    • 제27권4호
    • /
    • pp.194-200
    • /
    • 2009
  • 목 적: 위부분절제술 후 방사선치료를 받는 환자들 중에서 위 내 음식물의 배출지연으로 인한 위 용적 및 주변 장기의 위치 변화와 이것의 임상적 의의를 알아보고자 하였다. 대상 및 방법: 2005년 3월 1일부터 2008년 12월 31일까지 위암으로 위부분절제술을 받은 후 보조적 동시항암화학 방사선치료를 받았던 총 32명의 환자들 중, 전산화단층촬영모의치료 영상에서 12시간 이상의 금식에도 불구하고 위 내 음식물이 50 ml 이상 남아 잔존 위의 팽대를 보였던 경우들이 이번 연구 대상이었다. 이 환자들에 대해 방사선치료 기간 동안 주기적으로 시행된 컴퓨터단층촬영 자료를 바탕으로 잔존 위 용적 및 주변 장기들의 위치 변화를 평가하였다. 또한 방사선치료 설계 자료를 바탕으로, 잔존 위 및 주변 장기들의 변화를 고려하지 않고 치료를 지속했을 경우의 치료 표적 및 정상조직의 방사선분포 변화를 알아보았다. 결 과: 총 5명의 전산화단층촬영모의치료 영상에서 배출장애에 의한 50 ml 이상의 위 내 음식물의 저류가 확인되었다. 대상 환자들에서 위 용적은 치료과정 중에 다양한 변화양상을 보였고, 각 환자에서 최대 64.2~340.8 ml (평균, 188.2 ml)의 변화를 보였다. 또한 위 용적에 따라 좌측 신장이 각 환자별 최대 0.7~2.2 cm (평균, 1.2 cm)까지 상하 방향으로 이동하는 양상을 보였다. 모의치료 시의 설계를 위 용적의 변화에 따라 변경하지 않고 치료를 진행한 경우 유의하게 계획용표적체적(V43, 79.5${\pm}$10.4%)에 조사선량이 부족하고 좌측 신장(V20, 34.1${\pm}$12.1%; Mean dose, 23.5${\pm}$8.3 Gy)에 과도한 선량이 조사되는 결과를 얻을 수 있었다. 결 론: 위부분절제술 후 방사선치료를 받는 일부 환자에서 배출지연에 따른 위 용적의 변화와 좌측 신장의 위치변화를 확인할 수 있었다. 배출지연이 발생하는 환자를 선별하여 위 용적의 변화를 파악하고 이를 방사선치료 설계에 반영하는 것이 효과적일 것으로 생각된다.

Incarcerated Hiatal Hernia with Perforation after Laparoscopic Total Gastrectomy with Roux-en-Y Reconstruction: a Case Report

  • Wang, Nai-Yu;Tsai, Chung-Yu;Liu, Yuan-Yuarn;Chen, I-Shu;Ho, Kai-Hung
    • Journal of Gastric Cancer
    • /
    • 제19권1호
    • /
    • pp.132-137
    • /
    • 2019
  • The occurrence of hiatal hernia after total gastrectomy with Roux-en-Y reconstruction is rare. We report the case of a 76-year-old man who presented with dyspnea, vomiting, and fever around 8 days after total gastrectomy with Roux-en-Y reconstruction. Abdominal computed tomography revealed a hiatal hernia containing part of the small intestine in the left thoracic cavity. Emergent reduction and repair of the hiatal hernia were performed later. Operative findings revealed that the Roux limb was incarcerated in the left pleural cavity. Esophagojejunostomy leakage, perforation of the small intestine with transient ischemic change, and pyothorax were also found. Thus, feeding jejunostomy, thoracoscopic decortication, and diversion T-tube esophagostomy were performed. Considering that the main cause of hiatal hernia is blunt dissection with division of the phrenoesophageal membrane, approximating the crus with 1 or 2 figure-8 sutures, according to the size of the defect, to prevent the incidence of hiatal hernia after total gastrectomy may be performed.